Rohto Pharmaceutical. (4527.TSE) Q3 2025 Earnings

6AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
21
32
42
53

Details

Expected EPS
N/A
Actual EPS
53
Surprise EPS
53
Surprise Percent
+∞%

Description

Rohto Pharmaceutical. (4527.TSE) has reported earnings of 53 per share for Q3 2025.

0 Comments

Share your thoughts